Experience agency, Identity, has acquired Coda, a specialist healthcare communications agency.
The partnership creates IdentityCoda, which will strengthen Identity’s ability to support pharmaceutical and healthcare organisations with compliant, high impact events and experiences across global markets.
Founded in 2015, Coda has built a reputation for delivering technical excellence and creative clarity across global healthcare meetings, congress programmes and hybrid experiences.
The agency are trusted by some of the world’s top pharmaceutical companies, the agency transforms complex science into engaging experiences that unite audiences and drive understanding.
Olivier Vallee, CEO of Identity, said: “Advancement in healthcare is vital for us all. The organisations developing treatments, conducting research, and pushing scientific boundaries deserve environments where their expertise can shine. Bringing Coda into Identity gives us the privilege of supporting that mission with deeper capability and broader reach.”
He added: “We’re in the Golden Age of Experience, and the rate of change is accelerating. IdentityCoda will continue to operate with the specialist focus and expertise clients trust, now enhanced by Identity’s global infrastructure, complementary capabilities, and resources. Together, we can deliver more for healthcare organisations navigating increasingly complex communication challenges.”
IdentityCoda delivers end-to-end support for pharmaceutical and healthcare communications, including:
- Congress programmes and satellite symposia
- Investigator meetings and advisory boards
- Leadership programmes and internal communications
- Exhibition design and brand experiences
- Hybrid and virtual healthcare events
- Content production and scientific storytelling
- Strategic consultancy and compliance oversight
The agency operates from offices in Cheshire, UK, and Coimbra, Portugal, supporting clients across Europe, North America, Middle East and global markets.
Mark Owen, director at IdentityCoda, said: “Joining Identity strengthens our ability to serve pharmaceutical clients at scale while maintaining the specialist expertise and personal attention that defines how we work. Access to Identity’s technical innovation, creative talent, and global delivery network means we can support more ambitious programmes without compromising the precision and compliance healthcare communications demand.”
The acquisition responds to growing demand from pharmaceutical organisations for intergrated experience partners capable of delivering complex. compliant programmes at global scale.
IdentityCoda clients benefit from immediate access to Identity’s expanded creative, technical and production resources, further strengthening healthcare event delivery worldwide.